Vol. No. No. 45 Vol. 44 Vol. No.43 43 44 Founder FounderEditor: Editor: Founder Dr. Dr.A. A.Patani Patani A. Editor: Editor: Editor: Dr. Dr.Gopakumar GopakumarG. G.Nair Nair Dr. Gopakumar Nair Associate Associate Editors: AssociateEditors: Editors: J.L. Sipahimalani J.L.Sipahimalani Sipahimalani J.L. Dr. Dr.Nagaraj NagarajRao Rao Dr. Nagaraj Rao Dr. Dr.George GeorgePatani Patani George Patani President President Manish U. Manish U.Doshi Doshi S. V. Veerramani Immediate Past President Immediate Past President Immediate Past President N.R. N.R.Munjal Munjal Manish U. Doshi Vice-Presidents Vice-Presidents Vice-Presidents: Vice-Presidents: Vice-Presidents: (Western (WesternRegion) Region) Kamlesh Kamlesh C.Patel Patel KamleshC. C. Patel (Western Region) (Eastern (EasternRegion) Region) Subharthee Dey SubhartheeRoy DeyChowdhury Deepnath (Northern Region) (NorthernRegion) Region) (Eastern B.R. Sikri Sundeep V. B.R. Sikri Sundeep V.Bambolkar Bambolkar B. R. SikriRegion) (Southern (Southern Region) (Northern Region) S. S.V. V.Veerramani Veerramani T. Ravichandiran Hon. General Secretary Hon. General Secretary Hon. General Secretary Hon. General Secretary Bal Kishan Gupta (Southern Region) Bal Kishan Gupta Bharat N. Shah Bharat N. Shah Hon. Hon. Joint Secretaries Hon. General Secretary Hon. Joint Secretaries Hon.Joint JointSecretaries Secretaries Vinod Kalani Vinod Kalani M. Mahesh H. Doshi M.J.J.Shah Shah Pranav Choksi Pranav Choksi Pranav Choksi Pranav Choksi Hon. Joint Secretaries Hon. Treasurer Hon. Treasurer Hon. Treasurer Hon. Treasurer Mayank J. Shah Mahesh H. Mahesh H. Doshi Mahesh Doshi MaheshH. H.Doshi Doshi Bhavin M. Mehta For information For information contact IDMA Secretariat: For contact IDMA Secretariat: Forinformation informationcontact contactIDMA IDMASecretariat: Secretariat: Hon. Treasurer Daara B. Patel Daara B. Patel Daara B. Patel Daara B. Patel Bharat N. Shah Secretary-General Secretary-General Secretary-General Secretary-General T.R. Gopalakrishnan T.R. Gopalakrishnan For information contact IDMA Secretariat: T.R. Gopalakrishnan T.R. Gopalakrishnan Advisor Advisor Daara B. Patel Prachi PrachiRane Rane Secretary-General Sr. Sr.Manager Manager (Publications &&PR) T.R. Gopalakrishnan (Publications PR) Deputy Secretary-General C.K.S. Chettiar C.K.S. Chettiar C.K.S. Chettiar C.K.S. Chettiar Asst. Asst. Manager Asst. Manager Melvin Rodrigues Asst.Manager Manager (Publications) (Publications) (Publications) (Publications) Sr Manager (Commercial & Administration) C.K.S. Chettiar AAPublication Publicationof of AAPublication Publicationofof Asst. Manager (Publications & Administration) Indian Drug Manufacturers' Association Indian Drug Manufacturers' Association Indian Drug Manufacturers' Association Indian Drug Manufacturers' Association 102-B, 'A-Wing', Poonam Chambers 102-B,'A-Wing', 'A-Wing',Poonam PoonamChambers Chambers 102-B, A Publication ofChambers 102-B,Road, 'A-Wing', Poonam Dr. Dr.A.B. A.B. Road,Worli, Worli,Mumbai Mumbai--400 400018 018 Tel ::022-2494 4624 / 2497 4308 Fax: 022-2495 0723 Tel 022-2494 4624 / 2497 4308 Fax: 022-2495 0723 102-B, 'A-Wing', Poonam Chambers e-mail: / /[email protected] e-mail:[email protected] [email protected] [email protected] e-mail: / /[email protected] e-mail:[email protected] [email protected] [email protected] Dr.Website: A.B. Road,www.idma-assn.org Worli, Mumbai - 400 018 Website: www.idma-assn.org Website: Website: www.idma-assn.org Tel : 022-2494 4624 /www.idma-assn.org 2497 4308 Fax: 022-2495 0723 Published on Published on7th, 7th,14th, 14th,21st 21stand and30th 30thof ofevery everymonth month Published e-mail: mail_on [email protected]/[email protected] Published on7th, 7th,14th, 14th,21st 21stand and30th 30thofofevery everymonth month Dr. Road, Worli, Mumbai --400 Dr.A.B. A.B.4624 Road, Worli, MumbaiAssociation 400018 018 Indian Drug Manufacturers' Tel ::022-2494 / /2497 Tel 022-2494 4624 24974308 4308Fax: Fax:022-2495 022-24950723 0723 Website: www.idma-assn.org Annual AnnualSubscription Subscription Published on 7th, 14th, 21st and 30th of every month ````1000/1000/only (for IDMA members) 1000/only (for IDMA members) 1000/-only only(for (forIDMA IDMAmembers) members) Annual Subscription 3000/only (for non-members) 3000/only(for (fornon-members) non-members) ````3000/only 3000/only (for non-members) US$ 300 (Overseas) ` 1000/(for IDMA members) US$300 300(Overseas) (Overseas) US$ US$ 300 (Overseas) Please send your payment inin favour ofof ` 2000/(for Government Research/ Please send your payment favourof Please send your payment favour Please send your paymentinin favour of Educational Institutions) Indian Drug Manufacturers' Association Indian Drug Manufacturers' Association Indian Manufacturers' Association Indian`Drug Drug Manufacturers' Association 4000/(for non-members) US$ 400 (Overseas) OPINIONS EXPRESSED OPINIONS EXPRESSEDBY BYTHE THEAUTHORS AUTHORSOF OF Please send your payment in favour of INDIVIDUAL ARTICLES DO NECESSARILY INDIVIDUAL ARTICLES DONOT NOT NECESSARILY Indian Drug Manufacturers' Association Issue No. No. 48 Issue 22 Issue No. 29 29 22 22 01 to 30 December 2014 to 07 August June 2013 0108 toto 0714 August 2012 08 to 14 June2012 2013 IDMA ACTIVITIES: ADVISORY TO MEMBERS IDMA ACTIVITIES : : :: IDMA ACTIVITIES IDMA ACTIVITIES IDMA ACTIVITIES API China 2014 and 5th Sino-India Forum: A Brief Report & Glimpses.................8 SLA-Approved FDCs –onSubmission of––data ..........................................................................7 Drugs (Prices Control) Order 2013 Urgent Issues: IDMA .................4 IDMA Representation Unfair Limitation Criteria imposed on SSI units .......................... 14 Drugs (Prices Control) 2013 Urgent Issues: IDMA representation .................4 IDMA Representation Unfair Limitation imposed onrepresentation SSI unitsand .......................... 14 • Presentations on onOrder “Status Quo ofCriteria Chinese Generic Drugs GOVERNMENT NOTIFICATION : :: GOVERNMENT NOTIFICATIONS GOVERNMENT NOTIFICATIONS Business Opportunities in the future”: by Mr Zhang Mingyu .........................9 SERVICE TAX :: SERVICE TAXCIRCULAR CIRCULAR Pioglitazone suspension revoked with conditions-reg. ..........................................................8 Ban Dextropropoxyphene for human ................................................................5 Banon onInteractive Dextropropoxyphene for human use ................................................................5 IDMA Meeting with Ernst &use Young LLP and on effect of related GST on Draft Circular on leviability of service staff employment Draft Circular on leviability of service taxon on staffbenefits benefits andthe employment related GOVERNMENT COMMUNICATION : tax FDA COMMUNICATIONS : FDA COMMUNICATIONS : Pharmaceutical Manufacturers. . ..........................................................................13 transactionsreg ...............................................................................................................16 rd transactionsreg ...............................................................................................................16 Record of Discussion of 3 Meeting of the BHLG on Trade with Mexico-reg. ......................9 Drug Control) Order, 1995 Drug(Price (Price Control) Order, 1995.................................................................................6 .................................................................................6 IDMA delegation meets IPR :: CENTRAL EXCISE MATTERS : Shri J P Nadda, Hon’ble Minister for IPRMATTERS MATTERS IPR: IPR: Health & Family Welfare. . ....................................................................................13 Re-printing, re-labeling, re-packing or stickering Scheduled formulations in Intellectual Property Rights ininPharma Industry ............................................................... 18 Intellectual Property Rights Pharma Industry: :of ............................................................... 18 IPR ...........................................................................................................6 IPRNotifications Notifications ...........................................................................................................6 GOVERNMENT pursuance of the COMMUNICATIONS: provisions under the: DPCO 2013 exempted from CED-reg. ....................9 DRUGS & COSMETICS NOTIFICATIONS DRUGS & COSMETICS NOTIFICATIONS : Draft Rules to amend the Patents Rules, 2003 published – reg. .................................7 DraftMATTERS Rules to: amend the Patents Rules, 2003 published –(UCPMP) reg. .................................7 DGFT Uniform Code of Pharmaceuticals Marketing PracticesTrials – reg.............15 Drugs &&Cosmetics (3rd DrugsMATTERS Cosmetics (3rdAmendment) Amendment)for forconducting conductingClinical Clinical Trials–– DGFT ::NOTIFICATIONS: DGFT MATTERS Inclusion of Kattupalli Sea Port as a Port of Registration under Para 4.19 of HBP .............10 GOVERNMENT Draft DraftRules Rules2012 2012––reg. reg. ....................................................................................................27 ....................................................................................................27 Online and issue Certificatesfor export ofof Inviting suggestions to prevent unintended benefit under Incremental Onlineapplication application and issueof ofRegistration Registration Certificatesfor exportExport Drugs & Cosmetics Notification: Compensation Drugs & Cosmetics (4th Amendment) for Registration of Ethics Committee stst Registration of Ethics Committee Drugs &commodities Cosmetics (4th Amendment) various effective from July, 2013-reg. Incentivisation Scheme-reg. ................................................................................................11 various commodities effective from11for July,............................................................22 2013-reg...............................................15 ..............................................15 in cases ofRules Clinical Trial incidents – reg. (EC) ––Draft ––reg. ............................................................................................28 (EC) Draft Rules2012 2012 reg. ............................................................................................28 Amendment in Para 2.35(b) of FTP, 2009-2014-reg. ................................................16 Amendments in the Reward/Incentive Schemes of Chapter 3 of FTP Amendment in Para 2.35(b) of FTP, 2009-2014-reg. ................................................16 CENTRAL EXCISE Matters: Drugs (4th Rules 2012 ––I)-reg. reg..................................................... 31 Drugs&&Cosmetics (4thAmendment) Amendment) Rules 2012 reg..................................................... 31 2009-14 -Cosmetics Appendix 37D ofPara HBP of Procedure (Vol. .................................................11 Notification ofofIran ofofFTP, 2009-2014-reg. .................................16 Notification Iranunder under Para2.35(b) 2.35(b) FTP, 2009-2014-reg. .................................16 Amendment to CESTAT CUSTOMS NOTIFICATION : : Appeal Forms – reg. ...................................................25 CUSTOMS NOTIFICATION INTERVIEW : CORPORATE CORPORATEAFFAIRS AFFAIRSMATTERS: MATTERS: Inclusion of cases filed in exchange the Settlement Commission in the “Call-Book” - ...............13 reg........30 CBEC Custom new rates from Indian Pharma market needs strong regulatory set-up : Kiran Mazumdar-Shaw CBECnotifies notifies Custom new exchange ratesvalid valid from Power of ROCs totoobtain declaration/affidavits from Power of ROCs obtain declaration/affidavits fromsubscribers/first subscribers/first 02.08.2012 –Matters: reg. ...............................................................................................................33 customs 02.08.2012 – reg. ...............................................................................................................33 IPR MATTERS : directors directorsatatthe thetime timeofofincorporation-reg. incorporation-reg....................................................................17 ...................................................................17 NATIONAL NEWS India asks US to: :tighten patent regime to curb in misuse : Amiti Norms for Execution Bank Guarantee respect of Sen .....................................14 NATIONAL CUSTOMS MATTERS :: of CUSTOMSNEWS MATTERS NATIONAL NEWS : medicine AdvanceLicense/EPCG Schemes – reg.. . ...........................................................31 Union Govt’s free Policy to boost generic drug sales: Deloitte’s Director Union Govt’s free medicine Policy to boost generic drug sales: Deloitte’s Director............ ............34 34 24x7 Customs Operation atatMajor and Airports ––reg. 24x7of Customs Operation MajorPorts Ports and reg.......................................17 ......................................17 Drug war: Centre against companies’ move to Airports sellGoa old stocks at above-ceiling rates .....15 Re-warehousing of goods imported and/or procured GPMA urges DCGI to expedite process of notifying Port for import ........................... 34 GPMA urges DCGI to expedite process of notifying Goa Port for import ........................... 34 Customs permission for transhipment of goods/containers from a Customs for transhipment ofbranded goods/containers from a Lupin’s newpermission CEO eyes more revenue from drugs.................................................16 indigenously by EOU/EHTP/STP/BTP units -.............................................................. reg...............................................31 Scarce rains hit Pharma cos’ seasonal drug sales .............................................................. 35 Gateway Port to a CFS of another CS reg. ..............................................................18 Scarce rains hit Pharma cos’ seasonal drug sales 35 Gateway Port to a CFS of another CS reg. ..............................................................18 Revised drug prices: Pharma bodies challenge Govt fiat ....................................................16 Authentication of supply invoice/ARE-3 by the CE CBEC Madurai, inincontrols Tamil Nadu for ..................................................19 Committee backs retaining on ininCFS-reg. Pharma 36 Confusion over deadline to revise prices ....................................................................17 CBECnotifies notifies Madurai, Tamildrug Nadu for CFS-reg. ..................................................19 Committee backs retaining controls onFDI FDI Pharma....................................................... ....................................................... 36 th Authorities for claiming Deemed export benefits -7reg.. .......................................32 New Pharma Policy alone can’t make healthcare affordable ..............................................18 CBEC notifies New Exchange Rate with effect from 2013 Health more drugs for Compulsory CBECMinistry notifiesidentifying New Exchange Rate with effect from 7thJune June 2013--reg. reg...................20 ..................20 Health Ministry identifying moreessential essential drugs for Compulsory CBEC notifies Corrigendum in respect rate..........................................................18 of Exchange - reg......................32 Temporary drug likely DPCO of in force Licence as still on ..........................................................................................36 INTERVIEW :debate Licence asdebate stillrages rages ononce ..........................................................................................36 INTERVIEW : shortage th Pricing Order ................................19 No Excise Duty on re-labelling of generic drugs todrug comply with Dec. 2014 - reg........................33 CBEC notifies New Exchange Rates w.e.f. 19 India Health Progress terms free programme as critically important .............. 37 We Examining US Court’s on issue -critically Desiraju ...........21 India Health Progress terms freedecision generic drug programme as important .............. 37 Weare are Examining US Court’s decision onRanbaxy Ranbaxy issue -Keshav Keshav Desiraju ...........21 Drug industry still confused, despite directive on re-labelling prices ...................................19 NEW DEVELOPMENTS: WHO Prequalified List has more Generic Drugs from India than any Regulator turns down Pharma firms’ request for hike inininsulin price.................................. 38 WHO Prequalified List has more Generic Drugs from India than any Regulator turns down Pharma firms’ request for hike insulin price.................................. 38 New drug pricing order challenged in Court ........................................................................20 other country --suspension Nata Menabde ....................................................................................22 Gujarat girl designs pain-free insulin delivery system.........................................34 othercontrols country Natafor Menabde ....................................................................................22 Price ahead Patented Drugs............................................................................. 38 Centre revokes of manufacturing and sale of Pioglitazone ..............................21 Price controls ahead for Patented Drugs............................................................................. 38 Americans won’t go Indian Pharma because ofof...........................................34 Drugs for Ebola likely to45-day have an Indian connection. Americans won’t goagainst Indian Pharma because Cipla gets interim relief deadline ........................................................................21 Pharma firms looking toagainst pump in into units Pharma firms looking toon pump infunds funds intoIndian Indian unitsmay mayget getFIPB FIPBbreather breather................ ................39 39 Ranbaxy deeds: Kevin Ali, Merck Sharp &&at Dohme ....................................................23 Ranbaxy deeds: Kevin Ali, Merck Sharp Dohme ....................................................23 Ipca Labs, Lekar Pharma force NPPA to hike prices of 2 formulations ...............................22 Artificial blood for all groups developed DU lab. . .............................................35 Foreign ForeignInvestment InvestmentPromotion PromotionBoard Boarddefers defersPharmaceuticals Pharmaceuticals NATIONAL :: ...........................................................................................................40 Analgin set NEWS for comeback? ..................................................................................................22 NATIONAL NEWS sector FDI IPR FEATURE: sector FDIproposals proposals ...........................................................................................................40 Drugs Control Department forms squads to ensure fair price .............................................23 Pharma firms may expand reach totoprofit from higher volumes .................................25 Pharma firms may expand reach higher .................................25 Patented medicine and C Rfrom L Narasimhan. ....................................36 `profit scheme totovolumes Planning Commission panelaffordability: suggests `100-cr 100-cr scheme Planning Commission suggests Govt wants to agencies regulate panel e-cigarette astodrug ..........................................................................23 State trading may come rescue of Indian firms exporting totoIran State trading agencies may come to rescue of Indian firms exporting Iran............26 ............26 support extra-mural research ..............................................................................................40 support extra-mural research ..............................................................................................40 NPPA MATTERS Govt discontinues Annual Health Survey ............................................................................24 Commerce Dept bats for Pharma exporters ...............................................................26 Commerce Dept bats for Pharma exporters ...............................................................26 ` 2,000-cr Pharma Research Fund.............................................. 41 Exim Bank to implement 2,000-cr Pharma Fund.............................................. 41 Exim Bank to fixation implement Gujarat FDCA gears upofto`New enforce new pricesResearch for first batch of drugs..............................37 Retail Price Drug - DCG(i)'s approval - reg. PCI totonew come down heavily on colleges which lack required faculty && under DPCO from July in 29 ............................................................................................25 PCI come down heavily on colleges which lack required faculty 35-40% SME Pharma units Baddi want to sell off business 35-40% SME Pharma units in Baddi want to sell off business NATIONAL NEWS: infrastructure for BBPharm, MMPharm Trials trouble ....................................................................................................................26 infrastructure for Pharm, Pharmcourses courses............................................................27 ............................................................27 given ain claims industry...........................................................................................41 given achance; chance; claims industry...........................................................................................41 Pharma companies face price pressure inup US market........................................38 Clinical trial ofof untested drugs mustplans be regulated: SC .........................................................26 Department Health Research to set National Centre Department of Health Research plans to set up National Centrefor for World Pharma Trade Centre to be set up in AP .................................................................. 42 World Pharma Trade to in beBrownfield set up in APPharma..............................................39 .................................................................. 42 Strong pitch banCentre on FDI New rules halt for clinical trials by foreign firms .......................................................................27 Clinical Pharmacology ................................................................................................28 Clinical Pharmacology ................................................................................................28 Indian drug firms lobby against EU’s new directive ............................................................. 42 Indian Jan drug firms lobbyfrom against EU’s new directive ............................................................. 42 Pharma export growth India declines with slow down in US, From 1, Pharma companies can no longer gift freebies to doctors..............40 CDSCO initiate druggists expose temperature CDSCOtoto initiateaction actionagainst against druggistswho who expose temperature European markets, exporters seek government support .....................................................28 Govt takes call inintemperature Pharma ........................................................................................43 Govt takes callon on FDI Pharma ........................................................................................43 sensitive drugs totoFDI high ...........................................................................28 ‘Pharma industry may create 45k new jobs in 2015’: report................................41 sensitive drugs high temperature ...........................................................................28 US FDA asks Indian drugmakersto comply or IP face action ..................................................28 Pharmexcil asks Commerce Ministry totomake Pharmexcil Commerce Ministry make IPrecognized recognized Stock up drugs, wholesalers cutting supply ...........................................................29 Apex committee on clinical trials grants approval to 28 proposals......................41 Stock upon onasks drugs, wholesalers cutting supply ...........................................................29 US regulator tightens drug approval norms .........................................................................29 Globally to make Indian Drugs cheaper .............................................................................. 44 Globally to make Indian Drugs cheaperto.............................................................................. 44 Drug wholesalers may Mumbai .........................................................30 Glenmark to strengthen US with more generic ...................................... 42 Drugexpresses wholesalers mayhold holdpresence Mumbai toransom ransom .........................................................30 TAC concern over US attempt to curb supply offilings. affordable Price control may hit Multinational Pharmas ....................................................................... 45 Price control may hit Multinational Pharmas ....................................................................... 45 generic medicines from India ...............................................................................................30 Apollo Pharmacy halts sale of Ranbaxy drugs ...........................................................30 Apollowarns Pharmacy sale of Ranbaxy India Egypthalts companies against drugs selling...........................................................30 Sovaldi medicines........................42 Some key African recognition ofofIndian Pharmacopoeia soon ..... 45 AP relaxes banGets oncountries bulk drugcontemplating units’ expansion .....................................................................31 Some key African countries contemplating recognition Indian Pharmacopoeia soon ..... 45 Zydus Cadila Controllers Nod to launch Cholesterol Drug ...............................31 Zydus Cadila Gets Controllers Nod to launch Cholesterol Drug ...............................31 Clinical trial regulations to becare developed through consultative approach............43 Generic drugs may cut hepatitis costControllers ..........................................................................31 Health Ministry appoints 55Deputy Drugs atbigger CDSCO ininDelhi Health appoints Deputy Drugs Controllers CDSCO Delhi........................... ...........................46 46 Pharma Exports slow weak saves cos hit Pharma Exports slowdown, down, weak cosfrom fromat bigger hit.....................................32 .....................................32 Now, aMinistry toll-free number to report medicine reactions. .........................................44 FIPB clears 6 Brownfield Pharma FDIsaves proposals ................................................................31 Drug shortage likely as chemists run on limited stock ................................................32 Drug shortage likely as chemists run on limited stock ................................................32 FEATURE Health ministry launches ‘Teeka Express’ to protect children from Medical device industry cautions Government on FDI........................................44 FEATURE life-threatening diseases ......................................................................................................32 Hospitals, chemists totowait for on ......................................33 Hospitals, chemists wait forregulatory regulatoryword word onRanbaxy Ranbaxymoves ......................................33 Govt studying options as Novartis-Cipla patent dispute to Court.............45 The Pill Pushers ..................................................................................................................47 The Pill Pushers ..................................................................................................................47 Govt to revoke ban on Pioglitazone, .......................................................................33 INTERNATIONAL NEWS ::set up techAnalgin INTERNATIONAL NEWS Government plans to park for medical devices in Gujarat................46 INTERNATIONAL NEWS : New Newdrugs drugsfor forcancer cancerenlist enlistbody’s body’sdefenses defenses ............................................................33 ............................................................33 IDMA Calendar .........................................................................................................15 MHRA Appoints New Chief .................................................................................................34 IDMAEvent Event Calendar .........................................................................................................15 FEATURE FEATURE IDMA 53rd::Annual Day Celebrations Announcement, Advt. Tariff, “Employee Relations 2012 – Resurgence And Revival” National HRM th “Employee Relations 2012 –Convention Resurgence And Revival”(EFI (EFI National HRM 16 Pharmaceutical Analysts’ ...................................................................................... 4 Shortages ofofDrugs threaten TB fight .........................................................................35 Advt. Booking form, Registration and Programme details etc..................................4 Shortages Drugs threaten TBform fight .........................................................................35 nd Relations Conference) ............................................ Summit ––2012 &&won CIE 32 Employee Relations Conference) ............................................26 26 Summit 2012 CIE“e-INDIA 32ndEmployee FDCA, Gujarat has Health Award 2013 for XLN .................................................. 34 IDMA Event Calendar 2014-15........................................................................................24 nd Invitation for bids ACT Combi Packs &&Capsule Miltefosine .....................38 IDMA-APA Guideline technical monographs 32 National Conference on available “Governance, Risk Management &................................................ Compliance” (GRC).................. 35 2IDMA-APA Invitation for bidsfor fornow ACT CombiBlister Blister Packs Capsule Miltefosine .....................38 Guideline now available technical monographs ................................................ 32 Idma Holidays for the Year 2015........................................................................46 th APA-PAC 2013 Awards ................................................................................................ 36 16 EFI National Award Excellence ininEmployee EFIIDMA National Award for Excellence EmployeeRelations-2013 Relations-2013...............................39 ...............................39 Available DVD ofofIP 2010 .................................................................................................49 Available DVD IP–Card.................................................................................................48 –for 2010 .................................................................................................49 REPRESENT REPRESENTTHE THEOFFICIAL OFFICIALVIEW VIEWOF OFIDMA. IDMA. IDMA Tariff thth IDMA -Bulletin Quality Excellence Awards 2013 ....................................................................................... 37 Seminar on Barcode at 2.00 p.m. on 26 June 2013 at Mumbai ...............................40 Seminar on Barcode at 2.00 p.m. on 26 June 2013 at Mumbai ...............................40 OPINIONS EXPRESSED BY THE AUTHORS OF IDMA Publications ...............................................................................................................51 nd TM Publications ...............................................................................................................51 Exhibition - PharmaTech Expo .................................................................................... 3933 2IDMA IDMA Bulletin Subscription Form. .2013 ...................................................................................49 IDMA Bulletin XLIII 01 to 07 IDMA BulletinARTICLES XLIII(29) (29) 01 toNECESSARILY 07August August2012 2012 IDMA Event Calendar 2013 ........................................................................................39 INDIVIDUAL DO NOT IDMA Event Calendar 2013 ........................................................................................39 nd REPRESENT THE OFFICIAL OF IDMA. Advertisements ....................................................................................................... 2,50 41,to43-48 (29) 01 07 August 20132Advertisements IDMA Bulletin (22) to June 2013 Pharmaceutical Seminar IDMA BulletinXLIV XLIV (22)08 08VIEW to14 14 June 2013 2ndIndia–Japan India–Japan Pharmaceutical Seminar/ /Business BusinessMatching MatchingInInOsaka Osaka..................44 ..................44 . ....................................................................................2, 5233 IDMA Bulletin XLIV XLV (48) (38)22 08to to30 14December October 2013 2014 3 Advertisements Advertisements....................................................................................................2, ....................................................................................................2,46-52 46-52
© Copyright 2024 ExpyDoc
